Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...

Leading logistics company emphasizes risk mitigation

Our next company is Mullen Group Ltd. (TSX:MTL) , one of North America’s largest logistics providers, housing a network of independently operated businesses. We spoke with Randy Mercer, Director of Risk Management, who detailed the compa...

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...

ExoTherapy offers hope for treating acute spinal cord injuries

Suffering from traumatic injuries can leave a person with long-term damages and/or side effects that are hard to navigate long after the initial incident has passed. Our next company is a publicly traded bio-pharmaceutical company, working on the development of its ...

Buzz on the Bullboards: The Summer’s Most Talked About Sectors

The summer trading season is well underway as we celebrate a holiday here in Canada and this weekend in the US. Even on days that the markets were closed, the Bullboards on Stockhouse are wide open and busy with lively discussions on some of the biggest (and smallest) sto...

NervGen Pharma: A “Blockbuster Drug” in the Making?

It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern era, especially for treating Alzheimer’s disease. And that gives it considerable “blockbuster drug” potential – a tantalising opportunity tha...

Wanda Solution: The IoT and AI Evolution of Facility Management

(Image via Visionstate Corp.) There are plenty of unique opportunities for investors out there, but few are so unique that their platform has essentially no direct competition in the marketplace …. Headquartered in Edmonton, Alberta, Canada, Visionstate Cor...

Gratomic: Eco-conscious and On The Move

Graphite has been around for what it seems to be forever. I’m sure we all remember using a form of this naturally-occurring crystalline carbon as kids in our yellow No. 2 pencils. The popularity of this highly versatile mineral with other uses incl...

Augmented Reality Takes Sports Engagement to the Next Level

ImagineAR Inc. ( CSE: IP , OTCQB: IPNFF , Forum ) is a developer of augmented reality, (AR), platforms that are proving to be transformative for how we engage - and experience - immersive digital marketing campaigns. ...
1 2 3 4